High-Risk Secondary Myelofibrosis

Also known as: High risk Secondary Myelofibrosis

DrugDrug NameDrug Description
DB11697PacritinibA kinase inhibitor used for the treatment of primary and secondary myelofibrosis in adult patients with significantly reduced platelet counts.
DrugDrug NamePhaseStatusCount